|
⚲
|
| Keyboard |
| Aviezer David
✚
|
|
|---|---|
| CIK # | 0001385112 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001385112] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Protalix BioTherapeutics Inc | |
| Aviezer David |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-07-16 | Grant | 418,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Option exercise | 326,267 | $0.12 | 39,152 |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Option exercise | 123,733 | $0.97 | 120,021 |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2012-05-02 | Sell | 450,000 | $7.13 | 3,208,500 |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2012-05-02 | Option exercise | 326,267 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2012-05-02 | Option exercise | 123,733 | $0.00 |